Hospital Clinic Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (55)

2024

  1. Coping behaviors to reduce anxiety and depressive symptoms: A prospective repeated assessment study

    Spanish Journal of Psychiatry and Mental Health

  2. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 267, pp. 24-31

  3. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention

    Nutrition Journal, Vol. 23, Núm. 1

2023

  1. Examining associations, moderators and mediators between childhood maltreatment, social functioning, and social cognition in psychotic disorders: a systematic review and meta-analysis

    Psychological Medicine, Vol. 53, Núm. 13, pp. 5909-5932

  2. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

    Cells, Vol. 12, Núm. 6

  3. Improved estimation of the risk of manic relapse by combining clinical and brain scan data

    Revista de Psiquiatria y Salud Mental

  4. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

2022

  1. Negative schizophrenic symptoms as prefrontal cortex dysfunction: Examination using a task measuring goal neglect

    NeuroImage: Clinical, Vol. 35

  2. Social Functioning in Individuals Affected by Childhood Maltreatment: Establishing a Research Agenda to Inform Interventions

    Psychotherapy and Psychosomatics, Vol. 91, Núm. 4, pp. 238-251

  3. The network structure of cognitive deficits in first episode psychosis patients

    Schizophrenia Research, Vol. 244, pp. 46-54

  4. Validity of the Functioning Assessment Short Tests (FAST), in patients with schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 3, pp. 157-166

2021

  1. Difficulties in delivery and depressive symptomatology in schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 1, pp. 66-68

  2. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  3. Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive Symptoms

    Frontiers in Psychiatry, Vol. 12

  4. The transition time to gambling disorder: The roles that age, gambling preference and personality traits play

    Addictive Behaviors, Vol. 116

  5. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2020

  1. Neuropsychological, clinical and environmental predictors of severe mental disorders in offspring of patients with schizophrenia

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 270, Núm. 6, pp. 739-748

  2. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

    Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552

  3. Valoración de la mejoría clínica en niños y adolescentes con trastornos psiquiátricos: una evaluación de múltiples perspectivas con HoNOSCA

    Medwave, Vol. 20, Núm. 1, pp. e7762

2019

  1. Early detection of subtle motor dysfunction in cognitively normal subjects with amyloid-β positivity

    Cortex, Vol. 121, pp. 117-124